GOCO vs GSIW
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
GOCO exhibits severe financial distress, anchored by a critical Piotroski F-Score of 1/9, indicating a near-total failure of fundamental health metrics. The company is experiencing a catastrophic collapse in top-line performance with YoY revenue growth plummeting -96.80% and an operating margin of -252.92%. While the stock trades at a deep discount to book value (P/B 0.45) and sales (P/S 0.08), these appear to be value traps given the trajectory of the business. Despite a bullish analyst target of $4.70, the deterministic data suggests a company in a death spiral with a -99.4% five-year price return.
GSIW presents a high-risk profile characterized by a stable but mediocre Piotroski F-Score of 4/9 and a complete lack of deterministic value anchors like the Graham Number. While the company shows explosive YoY revenue growth of 414.60%, this is offset by catastrophic profitability metrics, including a profit margin of -93.20% and an operating margin of -192.20%. The stock's long-term price performance is devastating, with a 99.1% decline over five years, and technical trends remain entirely bearish. Despite a clean balance sheet with very low debt, the company is currently unable to monetize its growth into earnings.
Compare Another Pair
Related Comparisons
GOCO vs GSIW: Head-to-Head Comparison
This page compares GoHealth, Inc. (GOCO) and Garden Stage Limited (GSIW) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.